Madrigal's Cholesterol Drug Succeeds in Mid-Stage Trial Post author:Sam Post published:February 7, 2018 Post category:BioPharma MGL-3196 was well-tolerated with primarily mild and some moderate AEs. Source: BioSpace You Might Also Like <b>Scientist.com</b> Launches Next-Generation Innovation Hub For Cutting-Edge Drug Research Tools And Technologies August 29, 2017 <b>Mike Hooven</b>, Founder Of AtriCure And Enable Injections, Joins Genetesis Board Of Directors October 10, 2017 Why Struggling Bristol-Myers Squibb Could Take Out This Danish Biotech in Major ???500M Deal March 20, 2017
<b>Scientist.com</b> Launches Next-Generation Innovation Hub For Cutting-Edge Drug Research Tools And Technologies August 29, 2017
<b>Mike Hooven</b>, Founder Of AtriCure And Enable Injections, Joins Genetesis Board Of Directors October 10, 2017
Why Struggling Bristol-Myers Squibb Could Take Out This Danish Biotech in Major ???500M Deal March 20, 2017
